Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
Authors
Keywords
-
Journal
Blood Advances
Volume 5, Issue 12, Pages 2624-2643
Publisher
American Society of Hematology
Online
2021-06-21
DOI
10.1182/bloodadvances.2021004629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The use of 20% subcutaneous immunoglobulin replacement therapy in patients with B cell non-Hodgkin’s lymphoma with humoral immune dysfunction after treatment with rituximab.
- (2020) S Shahzad Mustafa et al. Clinical Lymphoma Myeloma & Leukemia
- Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
- (2020) Patricia Richi et al. CLINICAL RHEUMATOLOGY
- Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
- (2020) Derek K Chu et al. LANCET
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study
- (2019) S Bühler et al. RHEUMATOLOGY
- Depletion of B cells rejuvenates the peripheral B‐cell compartment but is insufficient to restore immune competence in aging
- (2019) Irit Avivi et al. AGING CELL
- Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study
- (2019) Patricia Richi et al. MEDICINA CLINICA
- Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome
- (2019) Manuela Colucci et al. Frontiers in Immunology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies
- (2017) Janie Parrino et al. VACCINE
- Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients
- (2016) Daryl R Cheng et al. Expert Review of Vaccines
- Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies
- (2015) Gunjan L. Shah et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The response to vaccination against influenza A(H1N1) 2009, seasonal influenza andStreptococcus pneumoniaein adult outpatients with ongoing treatment for cancer with and without rituximab
- (2014) Åke Berglund et al. ACTA ONCOLOGICA
- Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
- (2014) Meliha C Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies
- (2014) Yuichiro Ide et al. Human Vaccines & Immunotherapeutics
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
- (2013) I. Nazi et al. BLOOD
- Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab
- (2013) W. Kim et al. EUROPEAN JOURNAL OF NEUROLOGY
- Meta-analysis of prevalence
- (2013) Jan J Barendregt et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
- (2013) Meliha Crnkic Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens
- (2012) D. Bedognetti et al. BLOOD
- Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology
- (2012) Jordan S. Orange et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant
- (2012) Diego Villa et al. LEUKEMIA & LYMPHOMA
- A Prospective Study of the Factors Shaping Antibody Responses to the AS03-Adjuvanted Influenza A/H1N1 Vaccine in Cancer Outpatients
- (2012) A. F. Hottinger et al. ONCOLOGIST
- Viral Infections in Immunocompromised Hosts
- (2012) Mageshbabu Ramamurthy et al. Proceedings of the National Academy of Sciences, India. Section B
- Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
- (2011) O. E. Yri et al. BLOOD
- Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
- (2011) S. Audia et al. BLOOD
- Effect of rituximab on human in vivo antibody immune responses
- (2011) Mark D. Pescovitz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens
- (2011) D. Bedognetti et al. JOURNAL OF IMMUNOLOGY
- The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies
- (2011) Katherine Monkman et al. LEUKEMIA & LYMPHOMA
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
- (2011) U. Arad et al. VACCINE
- Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- (2010) Nicolas C. Issa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
- (2010) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies
- (2010) A. WONG et al. EPIDEMIOLOGY AND INFECTION
- Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
- (2010) H. de Lavallade et al. HAEMATOLOGICA
- Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment
- (2010) Helen J. Mackay et al. JOURNAL OF CLINICAL VIROLOGY
- Good and bad memories following rituximab therapy
- (2009) E. William St.Clair ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- Pertussis Immunity and Response to Tetanus-Reduced Diphtheria-Reduced Pertussis Vaccine (Tdap) after Autologous Peripheral Blood Stem Cell Transplantation
- (2009) Trudy N. Small et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy
- (2009) Olivier Thaunat et al. TRANSPLANTATION
- Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
- (2009) Magda Nakou et al. ARTHRITIS RESEARCH & THERAPY
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells
- (2008) M. Mamani-Matsuda et al. BLOOD
- Maintenance of the plasma cell pool is independent of memory B cells
- (2008) A. Ahuja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now